Question 1

What is SwissNeuroRehab?

Accepted Answer

SwissNeuroRehab is a Other.

Question 2

How often does SwissNeuroRehab appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was SwissNeuroRehab first tracked by Ergen?

Accepted Answer

First tracked on Jul 01, 2026.

Question 4

When was SwissNeuroRehab last mentioned in news?

Accepted Answer

Last active on Jul 01, 2026.

Question 5

What is SwissNeuroRehab's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is SwissNeuroRehab in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving SwissNeuroRehab?

Accepted Answer

MindMaze Therapeutics European Reimbursement Studies (Jul 01, 2026, 6 articles).

Question 8

How did the "MindMaze Therapeutics European Reimbursement Studies" event impact SwissNeuroRehab?

Accepted Answer

SwissNeuroRehab is a consortium that has enrolled the first patients in a High-Dose, High-Intensity (HDHI) neurorehabilitation study, which is powered by Coeptis Therapeutics Holdings's platform. This study is crucial for validating technology-supported neurorehabilitation pathways and securing reimbursement in Switzerland.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.